Professor Hemant Kocher

World Pancreatic Cancer Day at BCI with Professor Hemant Kocher

Professor Hemant Kocher whose research into pancreatic cancer is supported by charities including Pancreatic Cancer UK, Pancreatic Cancer Research Fund and P...

BBC Radio 4 - Inside Health, Robo-docs, using AI to diagnose; Pancreatic cancer; Statins and muscle aches

Are we on the cusp of a new era where computers will be doing the diagnosing?

🌍 Today on #worldpancreaticcancerday, we’re highlighting some of the ways our researchers are answering the toughest questions this disease poses to unlock better ways to tackle it. Pancreatic cancer remains one of the hardest types of cancer to treat, with only 5% of patients surviving their disease for 10 or more years. The disease often goes unnoticed until it reaches an advanced stage and has already spread, after which treatment becomes especially challenging. What’s more, this type of cancer embeds itself within a barrier of tough scar tissue, creating a fortress that shields the tumour from treatments and the immune system. We urgently need to understand the disease better to unlock ways to improve its poor outlook. 🟣New research published today sheds light on how star-shaped cells in the pancreas, called stellate cells, emit molecules that alter how aggressive the tumour is. The findings shed light on how we might better diagnose and treat this challenging cancer type. 📰Read the full story: https://www.bartscancer.london/general-news/2023/11/world-pancreatic-cancer-day-research-reveals-molecules-that-alter-the-diseases-spread/ 🟣Professor Hemant Kocher, who led today’s new study, is also running a clinical trial called STARPAC, which is testing a way to reduce the fortress of scar tissue that forms around pancreatic cancer. They hope that this will improve other treatments’ chances of breaching the cancer’s defences and defeating it. 🟣Professor Tatjana Crnogorac-Jurcevic is leading the UroPanc trial, which is investigating a way to spot early signs of pancreatic cancer in urine. This research could help us catch the disease at an earlier stage when it is easier to treat. 🟣Professor Claude Chelala and her team are investigating how we could design a blood test to detect fragments of DNA from pancreatic cancer cells. This could help doctors to track how the disease is evolving and tailor patients’ treatments to tackle their unique disease. Many more researchers across the BCI are studying pancreatic cancer from every angle. Follow us or visit www.bartscancer.london to stay up to date with the latest progress. #pancreaticcancerawarenessmonth #cancerresearch #pancreaticcancer | Barts Cancer Institute

🌍 Today on #worldpancreaticcancerday, we’re highlighting some of the ways our researchers are answering the toughest questions this disease poses to unlock better ways to tackle it. Pancreatic...